1CRF development from the standpoint of clinical data managementBU Qing-yan, XIONG Ning-ning, ZOU Jian-dong, JIANG Meng, LIU Fang339-3432New synthetic antibacterial agentsYUAN Yong, ZHOU Cheng-he, LIU Qiang, SONG Chun-ze343-3503Bioactivities and clinical applications of flavonoidsZHOU Xin, LI Hong-jie350-3554Factors affecting drug release by nasal delivery systemLI Miao, GAO Yong-liang356-3605Development of process parameters of wet-granulationWANG Hong, GUO Dai-hong, LIU Gui-yang361-3656Inhibition of HIV-1 protease in vitro with escins and ursolic acid derivativesYANG Xiu-wei, ZHAO Jing, MA Chao-mei, HATTORI Masao366-3697Toxicity assessments of anti-HIV drug candidates DCK derivativesLIU Mi-feng, PENG Shuang-qing, CHEN Xian-hong, LIU Kun, XIE Lan, GUO Jia-bin, WANG Yi-mei, YANG Hai-ying, YAN Chang-hui, WANG Guo-qiang370-3738Inhibition of Coxsackie virus B3 with aqueous extracts from Spatholobus suberectus in vitroGUO Jin-peng, PANG Ji, WANG Xin-wei, SHEN Zhi-qiang, JIN Min, LI Jun-wen374-3779Modulation of the proliferation of mouse spleen lymphocytes by 3,19-ketal andrographolide derivativesDAI Gui-fu, XU Hai-wei, WANG Jun-feng, LI Qi-ke, WANG Fang, XU Man, LIU Hong-min378-38110Dissolution in vitro and pharmacokinetics of levofloxacin hydrochloride sustained-release tabletsLI Wen-ping, YIN Li-fang, ZHAO Cun-jie, JIANG Zhen-zhou, ZHANG Lu-yong, CHEN Mao, YE Fang, FANG Yu-xin381-38511Synthesis of Men-10700CHEN Xiao-fang, HAN Hong-na, LI Hao, LIU Jun385-38712Preparation of actinomycin D vaginal bioadhesive tabletDU Li-dong, NI Jing-man, MENG Qing-gang, SHI Yan-bin387-39013A randomized, double-blind and parallel control clinical study to evaluate faropenem sodium tablets versus cefuroxime axetil tablets in the treatment of respiratory bacterial infectionsDENG Hui, HUANG Wen-xiang, LIU Cheng-wei, ZHOU Xiang-dong, ZHANG Wei-li, YU Ying-jie, ZHU Wei-min, ZHANG Gen-fu, ZHANG Hui, ZHANG Dao-you391-39514A multicenter randomized double blind parallel control clinical trial for amoxicillin and clavulanate potassium chewable tablet in the treatment of acute bacterial infectionsGUI Bao-song, JIA Li-ning, TAN Ting, WANG Ting, SUN Xiu-zhen, CUI She-huai, JIN Feng-shuo, HAN Xue-fang, WANG Yang-wei395-39815Comparison of statistical considerations in clinical trials of antibacterial agentsZHU Sai-nan, YAO Chen399-40216Relative bioavailability of enoxacin dispersible tabletsTAN Zhi-rong, OUYANG Dong-sheng, HAN Yang, PENG Liang, CHEN Yao, HAN Chun-ting, ZENG Ling, GUO Dong, ZHENG Jiao, ZHOU Gan, WANG Lian-sheng, LI Zhi, LIU Zhao-qian, HU Dong-li, LIU Ying-zi, WANG Dan, ZHOU Hong-hao403-40517Retrospective analysis on β-lactam antibiotics consumed in 6 cities of the Yangtze River valley in 2003-2005FENG Lin, HOU Xiao-yun, MENG Ling, DAI Hui-zhen, TAO Lin407-409,41318Micafungin:a new echinocandin antifungal agentXIA Lu-feng, LI Yang, FU De-xing410-41319Pharmacology and clinical evaluation of doripenemPENG Ka, YANG Xiu-zhen, LU Yi414-416 